Literature DB >> 24866875

Headache: Medication overuse headache--seeking a management consensus.

Michael Bjørn Russell1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24866875     DOI： 10.1038/nrneurol.2014.85

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.

Authors:  H C Diener; D W Dodick; S K Aurora; C C Turkel; R E DeGryse; R B Lipton; S D Silberstein; M F Brin
Journal:  Cephalalgia       Date:  2010-03-17       Impact factor: 6.292

2.  OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Authors:  S K Aurora; D W Dodick; C C Turkel; R E DeGryse; S D Silberstein; R B Lipton; H C Diener; M F Brin
Journal:  Cephalalgia       Date:  2010-03-17       Impact factor: 6.292

3.  The International Classification of Headache Disorders, 3rd edition (beta version).

Authors: 
Journal:  Cephalalgia       Date:  2013-07       Impact factor: 6.292

4.  Reduction in medication-overuse headache after short information. The Akershus study of chronic headache.

Authors:  R B Grande; K Aaseth; J Š Benth; C Lundqvist; M B Russell
Journal:  Eur J Neurol       Date:  2011-01       Impact factor: 6.089

5.  Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness.

Authors:  P Zeeberg; J Olesen; R Jensen
Journal:  Cephalalgia       Date:  2006-10       Impact factor: 6.292

6.  Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

Authors:  Stephen D Silberstein; Richard B Lipton; David W Dodick; Frederick G Freitag; Nabih Ramadan; Ninan Mathew; Jan L Brandes; Marcelo Bigal; Joel Saper; Steven Ascher; Donna M Jordan; Steven J Greenberg; Joseph Hulihan
Journal:  Headache       Date:  2007-02       Impact factor: 5.887

7.  A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study.

Authors:  C Tassorelli; R Jensen; M Allena; R De Icco; G Sances; Z Katsarava; M Lainez; Ja Leston; R Fadic; S Spadafora; M Pagani; G Nappi
Journal:  Cephalalgia       Date:  2014-02-20       Impact factor: 6.292

8.  The Severity of Dependence Scale detects people with medication overuse: the Akershus study of chronic headache.

Authors:  R B Grande; K Aaseth; J Saltyte Benth; P Gulbrandsen; M B Russell; C Lundqvist
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-03-11       Impact factor: 10.154

9.  Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akershus study of chronic headache.

Authors:  K Aaseth; R B Grande; K J Kvaerner; P Gulbrandsen; C Lundqvist; M B Russell
Journal:  Cephalalgia       Date:  2008-05-21       Impact factor: 6.292

10.  Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Authors:  H-C Diener; G Bussone; J C Van Oene; M Lahaye; S Schwalen; P J Goadsby
Journal:  Cephalalgia       Date:  2007-04-18       Impact factor: 6.292
  10 in total
  1 in total

1.  Nucleus accumbens functional connectivity discriminates medication-overuse headache.

Authors:  D M Torta; T Costa; E Luda; M G Barisone; P Palmisano; S Duca; G Geminiani; F Cauda
Journal:  Neuroimage Clin       Date:  2016-05-14       Impact factor: 4.881
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.